» Articles » PMID: 22235752

The Pathogenesis of COPD and IPF: Distinct Horns of the Same Devil?

Overview
Journal Respir Res
Specialty Pulmonary Medicine
Date 2012 Jan 13
PMID 22235752
Citations 76
Authors
Affiliations
Soon will be listed here.
Abstract

New paradigms have been recently proposed in the pathogenesis of both chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF), evidencing surprising similarities between these deadly diseases, despite their obvious clinical, radiological and pathologic differences. There is growing evidence supporting a "double hit" pathogenic model where in both COPD and IPF the cumulative action of an accelerated senescence of pulmonary parenchyma (determined by either telomere dysfunction and/or a variety of genetic predisposing factors), and the noxious activity of cigarette smoke-induced oxidative damage are able to severely compromise the regenerative potential of two pulmonary precursor cell compartments (alveolar epithelial precursors in IPF, mesenchymal precursor cells in COPD/emphysema). The consequent divergent derangement of signalling pathways involved in lung tissue renewal (mainly Wnt and Notch), can eventually lead to the distinct abnormal tissue remodelling and functional impairment that characterise the alveolar parenchyma in these diseases (irreversible fibrosis and bronchiolar honeycombing in IPF, emphysema and airway chronic inflammation in COPD).

Citing Articles

A roadmap for developing and engineering pulmonary fibrosis models.

Dabaghi M, Carpio M, Saraei N, Moran-Mirabal J, Kolb M, Hirota J Biophys Rev (Melville). 2024; 4(2):021302.

PMID: 38510343 PMC: 10903385. DOI: 10.1063/5.0134177.


Advanced lung organoids for respiratory system and pulmonary disease modeling.

Joo H, Min S, Cho S J Tissue Eng. 2024; 15:20417314241232502.

PMID: 38406820 PMC: 10894554. DOI: 10.1177/20417314241232502.


Comorbidity of Pulmonary Fibrosis and COPD/Emphysema: Research Status, Trends, and Future Directions --------- A Bibliometric Analysis from 2004 to 2023.

Fang H, Dong T, Han Z, Li S, Liu M, Liu Y Int J Chron Obstruct Pulmon Dis. 2023; 18:2009-2026.

PMID: 37720874 PMC: 10505036. DOI: 10.2147/COPD.S426763.


The association between leukocyte telomere length and chronic obstructive pulmonary disease is partially mediated by inflammation: a meta-analysis and population-based mediation study.

Wang T, Jia Z, Li S, Li Y, Yu T, Lu T BMC Pulm Med. 2022; 22(1):320.

PMID: 35987624 PMC: 9392327. DOI: 10.1186/s12890-022-02114-8.


Syndrome of Combined Pulmonary Fibrosis and Emphysema: An Official ATS/ERS/JRS/ALAT Research Statement.

Cottin V, Selman M, Inoue Y, Wong A, Corte T, Flaherty K Am J Respir Crit Care Med. 2022; 206(4):e7-e41.

PMID: 35969190 PMC: 7615200. DOI: 10.1164/rccm.202206-1041ST.


References
1.
Chilosi M, Zamo A, Doglioni C, Reghellin D, Lestani M, Montagna L . Migratory marker expression in fibroblast foci of idiopathic pulmonary fibrosis. Respir Res. 2006; 7:95. PMC: 1538593. DOI: 10.1186/1465-9921-7-95. View

2.
Minagawa S, Araya J, Numata T, Nojiri S, Hara H, Yumino Y . Accelerated epithelial cell senescence in IPF and the inhibitory role of SIRT6 in TGF-β-induced senescence of human bronchial epithelial cells. Am J Physiol Lung Cell Mol Physiol. 2011; 300(3):L391-401. PMC: 3284316. DOI: 10.1152/ajplung.00097.2010. View

3.
Mannino D, Buist A . Global burden of COPD: risk factors, prevalence, and future trends. Lancet. 2007; 370(9589):765-73. DOI: 10.1016/S0140-6736(07)61380-4. View

4.
Pauwels R, Buist A, Calverley P, Jenkins C, Hurd S . Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med. 2001; 163(5):1256-76. DOI: 10.1164/ajrccm.163.5.2101039. View

5.
Flores I, Blasco M . The role of telomeres and telomerase in stem cell aging. FEBS Lett. 2010; 584(17):3826-30. DOI: 10.1016/j.febslet.2010.07.042. View